Home › Interstitial Cystitis › NCT05149573
Investigation of PEMF Therapy for Female Patients With IC/BPS
Investigation of Non-Invasive Pulsed Electromagnetic Field (PEMF) Therapy for Female Patients With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
Who can join
Ages 18 to 80 · Women
Full eligibility criteria
Inclusion Criteria: * Previously established clinical diagnosis of IC/PS * Current numeric rating scale (NRS) score of ≥ 6 * History of cystoscopy with hydrodistension with bladder capacity determination under anesthesia * No cognitive deficits Exclusion Criteria: * History of bladder, ovarian, vaginal cancer * History of urethral diverticulum * History of radiation cystitis * History of spinal cord injury or spina bifida * History of Parkinson's disease, multiple sclerosis, or stroke * Current placement of a pacemaker or metal prosthesis * Active urinary tract infection * BMI \> 40 * Residual urine of \> 100cc * Current pregnant
About the study
The purpose of this study is to gather information about the safety and effectiveness of the non-pharmacological (non-drug), non-invasive treatment known as low-frequency pulsed electromagnetic field (PEMF) therapy. The study team will distribute the PEMF device to female adults with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) to measure its ability to decrease bladder and pelvic pain as well as other urinary symptoms associated with IC/BPS. There are two sequential Aims in this study and subjects will be recruited to participate in only one Aim. In both Aims, data will be collected at baseline/enrollment, 4-weeks after using PEMF therapy, and 8, 12, and 16 weeks post-enrollment.
What is being tested
- Pulsed Electromagnetic Field (PEMF) Device (device)
- Sham Pulsed Electromagnetic Field (PEMF) Device (device)
Sponsor: Wake Forest University Health Sciences · Participants: 75 · Started: Aug 29, 2022
Contact the study team
- Stephen J Walker, PhD · Phone: 336-713-7272
- Kaylee A Ferrara, BS · Phone: 336-713-1693
Official record on ClinicalTrials.gov — NCT05149573
Locations in the U.S.
| North Carolina | Wake Forest University Health Sciences, Winston-Salem |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.